Pure Health Holding Pjsc · ADX:PUREHEALTH
Pure Health Holding Pjsc — PureHealth — Q1 2025 Earnings Presentation
37 slides from Pure Health Holding Pjsc's earnings presentation, May 2025
Slide 1: Earnings Presentation 1Q 2025
Earnings Presentation 1Q 2025 May 2025
Slide 2: Contents
Financial and Operating Highlights 3 Contents Overview & Strategy 4 Group Financial Results 7 Healthcare Segment Review 11 Insurance Segment Review 19 Other Segments Updates 22 Outlook & Guidance 24 Appendix 26
Slide 3: 1Q 2025 Financial and Operating Highlights
1Q 2025 Financial and Operating Highlights Strong Start to 2025 Demonstrates Stability and Growth Financial results (YoY) Operational metrics (YoY) Shareholder value Dividend AED 6.6 Bn Outpatient 2.2 Mn distributed Revenue Volume AED 343 Mn +8% +9% (20% of FY24 Net Profit) AED 1.1 Bn Inpatients
Slide 4: Overview & Strategy
+ PURZHYALTH Overview & Strategy
Slide 5: PureHealth Today: Expanding Global Healthcare Platform
PureHealth Today: Expanding Global Healthcare Platform UAE Roots, Global Reach: Elevating Healthcare Leadership Middle East’s Largest Healthcare 27,000+ 24 c.5,000 Group Employees Hospitals Licensed Beds 143+ 70+ 52 Mn+ UAE Laboratories Pharmacies Claims UK’s Largest 2,000+ Private 9,000+ 50+ Employ
Slide 6: Strategic Imperatives Recap
Strategic Imperatives Recap Building a Resilient, Technology-Enabled Global Healthcare Ecosystem Unique Payer Economies of Strategic Global Cutting-Edge Provider Model Scale and Scope Footprint Technology The model integrates: • Centralize • Expand market • Expand Digital • Hospitals / Clinics procu
Slide 7: Group Financial Results
+ PURZHYALTH Group Financial Results
Slide 8: 1Q 2025 Group Financial Performance
1Q 2025 Group Financial Performance 2025 Off to a Strong Start with Robust Year-on-Year Earnings Growth Revenue EBITDA Net profit +8% +5% +3% AED 6.6 Bn AED 1.1 Bn AED 0.5 Bn 14.0% 5.4% 9.6% 3.1% 7.5% 11.8% 1.8% 2.0% 2.7% 22.1% 18.3% 59.1% 30.4% 45.6% 66.8% ● Hospital and Other Healthcare Related Se
Slide 9: 1Q 2025 Performance Reflects Broad-Based Growth and Ongoing Expansion
1Q 2025 Group Financial Performance 1Q 2025 Performance Reflects Broad-Based Growth and Ongoing Expansion Total Revenue Movement YoY (AED Mn) 1Q 2025 EBITDA Movement by segments (AED Mn) 1Q 2025 +8% +5% 113 87 (226) 296 6,581 1,081 (33) (2) (1) 8 (1) 81 1,133 166 31 6,115 Healthcare: -3% (AED -28 Mn
Slide 10: Strong Balance Sheet with No Bank Debt and Ample Growth Capacity
1Q 2025 Group Financial Performance Strong Balance Sheet with No Bank Debt and Ample Growth Capacity Cash & Bank Balance (AED Bn) Total Assets (AED Bn) 7.2 Net Debt* / EBITDA CAPEX as % of Revenue 47.8 ▼ -39% year-to-date Trade & Other Receivables (AED Bn) ▼ -2% year-to-date 6.9 +42% year-to-date
Slide 11: Healthcare Segment Review
+ PURZHYALTH Healthcare Segment Review
Slide 12: Largest Healthcare Network in the UAE with End-to-End Patient Access
UAE Hospitals & Clinics Largest Healthcare Network in the UAE with End-to-End Patient Access Digital Front Door Primary Clinics Hospitals 575k+ members 60+ Clinics & Visa Screening Centers 24 Hospitals 240+ Hospital specialty clinics Sheikh Khalifa Hospitals Northern Emirates PureHealth Earnings Pre
Slide 13: Largest Number of Tertiary Care Hospitals and Specialities Across UAE
UAE Hospitals & Clinics Largest Number of Tertiary Care Hospitals and Specialities Across UAE Tertiary Care Hospitals UAE’s Largest Speciality Services and Tertiary Care Network 24 11 Hospitals Tertiary Care 700+ 4 Sheikh Khalifa Hospitals Northern Emirates Transplants Oncology Centers 229 c.5,000 P
Slide 14: UAE Organic Growth: Higher Patient Volumes & More Complex Care
UAE Hospital & Clinics: Key Performance Metrics UAE Organic Growth: Higher Patient Volumes & More Complex Care Outpatient Volumes Emergency Department Volumes (in Thousands) 1,638 (in Thousands) 248 1,470 234 +11% +6% 1Q 2024 1Q 2025 1Q 2024 1Q 2025 Inpatient Volumes Bed Occupancy (in Thousands) (%,
Slide 15: Circle Health UK: Overview and Strategic Fit
Circle Health UK: Overview and Strategic Fit Strategic Global Expansion: Leading Presence in UK Private Healthcare №1 43% Private provider in Private Market the UK Share 50+ 2 Mn+ Hospitals Annual Patient Visits Investment Highlights: • Structural demand tailwinds, comprising an ageing population an
Slide 16: Circle - Year One: Accelerating Growth, Robust Margins, Ongoing Integration
Circle Health UK: Key Performance Highlights Circle - Year One: Accelerating Growth, Robust Margins, Ongoing Integration Revenue EBITDA (in GBP Mn) (in GBP Mn) 78 277 339 254 1,280 324 1,205 68 +6% +5% +9% +14% FY 2023 FY 2024 1Q 2024 1Q 2025 FY 2023 FY 2024 1Q 2024 1Q 2025 Total Patient Interaction
Slide 17: Driving Strategic Growth via Service, Capacity Expansion & Clinical Innovation
Strategy Execution and Growth Priorities Update Driving Strategic Growth via Service, Capacity Expansion & Clinical Innovation • Launched the Liver Transplant Program – • Expanded Cardiac Diagnostic Centre by adding • Secured the largest European order of Velys completed 10+ procedures to date in 9
Slide 18: Group-Wide Execution in Complex Care with Strong Clinical Performance
Group Complex Procedures Overview Group-Wide Execution in Complex Care with Strong Clinical Performance 10+ Liver Transplants were successfully Rare & Complex Pediatric Surgeries carried out in 1Q 25 • Subtotal laparoscopic pancreatectomy in a 4- month-old for nesidioblastosis Pediatric Neurology tr
Slide 19: Insurance Segment Review
+ PURZHYALTH Insurance Segment Review
Slide 20: Insurance Delivers Double-Digit Surge on Robust Performance
Insurance: 1Q 2025 Performance Highlights Insurance Delivers Double-Digit Surge on Robust Performance #1 A 3.2 Mn 13.9 Mn Health Insurance Rating for 5 +6% YoY +9% YoY Player in UAE consecutive years by Members Claims S&P Global Insured Processed Health Insurance segment’s 1Q 2025 financial result
Slide 21: Focus Areas Supporting Market Expansion and Service Excellence
Insurance: Strategy and Business Drivers Focus Areas Supporting Market Expansion and Service Excellence Growth Distribution Operational Customer Excellence Centricity Expand our Strengthen and Enhance efficiency Increased government and diversify distribution and performance retention of high- comme
Slide 22: Other Segments Updates
+ PURZHYALTH Other Segments Updates
Slide 23: Key Platform Developments in Procurement, Diagnostics, and Digital Health
Execution Progress Across Other Segments Key Platform Developments in Procurement, Diagnostics, and Digital Health • Partnered with the Ministry of Foreign • Launched the Abu Dhabi Public Health • Enabled electronic prescription intake, Affairs for international projects in the Centre Surveillance L
Slide 24: Outlook and Guidance
+ PURZHYALTH Outlook and Guidance
Slide 25: On Track Toward Medium-Term Strategic and Financial Targets
Guidance for 2025 and the Medium-Term On Track Toward Medium-Term Strategic and Financial Targets Revenue International EBITDA CAPEX as % of Net Debt** / growth revenue share* Margin Revenue EBITDA FY 2024 Results +58% 18.1% 15.9% 3.7% 0.9x Medium-Term Mid-to High Target c.50% Low 20s <5% 3.0x *** (
Slide 26: Appendix
+ PURZHYALTH Appendix
Slide 27: Overview of Our Synergistic Portfolio of Healthcare Assets
Appendix Overview of Our Synergistic Portfolio of Healthcare Assets Hospitals Health Insurance Procurement Diagnostics Technology 1Q 2025 Segment Value & Contribution in % Revenue AED 4,984 Mn (59%) AED 1,864 Mn (22%) AED 1,177 Mn (14%) AED 261 Mn (3%) AED 152 Mn (2%) EBITDA AED 767 Mn (67%) AED 210
Slide 28: Financial Performance Positively Impacted by Expansion of All Businesses
Appendix Financial Performance Positively Impacted by Expansion of All Businesses AED Mn 1Q 2025 1Q 2024 Δ% Net Profit Movement (AED Mn) 1Q 2025 Revenue 6,581 6,115 +8% Cost of sales* (4,833) (4,486) +8% +3% Gross profit 1,748 1,629 +7% G & A expenses, incl.selling & 466 (347) (1,156) (1,065) +9% 49
Slide 29: Revenue Growth Driven by Solid Performance Across Business Segments
Appendix Revenue Growth Driven by Solid Performance Across Business Segments Revenue (AED Mn) 1Q 2025 Total Revenue Movement YoY (AED Mn) 1Q 2025 +8% +8% 6,115 166 31 113 87 (226) 296 6,581 6,388 6,452 6,892 6,581 6,115 +3% +14% +11% +132% +14% +19% +4% +1% +7% -5% 1Q 24 Hospital and Diagnostic Proc
Slide 30: EBITDA Reached AED 1.1 Bn Yielding Margin Expansion to 5%
Appendix EBITDA Reached AED 1.1 Bn Yielding Margin Expansion to 5% Total EBITDA (AED Mn) 1Q 2025 EBITDA Movement by segments (AED Mn) 1Q 2025 +5% +5% 1,081 (33) (2) (1) 8 (1) 81 1,133 1,081 1,076 1,133 970 993 -4% -2% -2% +59% +9% +63% -0% -10% +2% +14% 1Q 24 Hospital and Diagnostic Procurement Tech
Slide 31: Robust Balance Sheet
Appendix Robust Balance Sheet AED Mn Mar 31, 2025 Dec 31, 2024 Δ% Total Assets Movement (AED Bn) 1Q 2025 Total Non-Current Assets 26,591 25,844 +3% -2% incl. Intangible Assets 8,745 8,644 +1% 48.6 2.0 (4.7) 1.9 47.8 incl. Right of use assets 11,110 11,019 +1% Total Current Assets 21,198 22,731 -7% +
Slide 32: 1Q 2025: Hospitals and Other Related Services
Appendix 1Q 2025: Hospitals and Other Related Services Revenue (AED Mn) Gross profit (AED Mn) EBITDA (AED Mn) Margin Net profit (AED Mn) Margin 15.4% 5.3% 4,984 1,460 767 262 ▲ +3% year-on-year ▼ -1% year-on-year ▼ -4% year-on-year ▼ -13% year-on-year Key Operational Stats for UAE (thousands) Outpat
Slide 33: Q1 2025: Health Insurance
Appendix Q1 2025: Health Insurance Revenue (AED Mn) Gross profit (AED Mn) EBITDA (AED Mn) Margin Net profit (AED Mn) Margin 11.3% 9.4% 1,864 226 210 174 ▲ +19% year-on-year ▲ +54% year-on-year ▲ +63% year-on-year ▲ +72% year-on-year 13.9 Mn claims processed +9% YoY in 1Q’25 151% Solvency Ratio -6 pp
Slide 34: 1Q 2025: Procurement and Supply of Medical-Related Products
Appendix 1Q 2025: Procurement and Supply of Medical-Related Products Revenue (AED Mn) Gross profit (AED Mn) EBITDA (AED Mn) Margin Net profit (AED Mn) Margin 5.3% 4.7% 1,177 104 63 55 ▲ +11% year-on-year ▲ +10% year-on-year -2% year-on-year -1% year-on-year Business Partnerships Total Procuremen
Slide 35: Q1 2025: Diagnostic Services
Appendix Q1 2025: Diagnostic Services Revenue (AED Mn) Gross profit (AED Mn) EBITDA (AED Mn) Margin Net profit (AED Mn) Margin 33.1% 26.0% 261 114 86 68 ▲ +14% year-on-year ▲ +16% year-on-year -2% year-on-year -6% year-on-year Business Expansion Abu Dhabi Public Health Centre Surveillance 143+
Slide 36: 1Q 2025: Technology Services and Others
Appendix 1Q 2025: Technology Services and Others Revenue (AED Mn) Gross profit (AED Mn) EBITDA (AED Mn) Margin Net profit (AED Mn) Margin 15.1% 10.3% 152 ▲ +132% year-on-year 45 ▲ +162% year-on-year 23 ▲ +59% year-on-year 16 ▲ +46% year-on-year Business Achievements PureNet, a digital health-as-a-se
Slide 37: PureHealth Investor Relations
Thank you for attending! Should you have any questions or queries, please reach us. PureHealth Investor Relations https://purehealth.ae/investor-relations/ ir@purehealth.ae